Medical researchers are always looking to develop new medications to alleviate pain for patients with chronic pain. Recently, researchers made a discovery that could lead to a new drug that could help patients with spinal cord injuries deal with chronic pain. Patients in Colorado may benefit from this new pain medication when it becomes available.
According to research, acrolein is a neurotoxin produced by the human body in response to injured nerve cells. This neurotoxin may end up worsening a patient's injury, and subsequently, the pain associated with it. There is a medication called hydralazine that is currently only approved to treat high blood pressure.
Studies show that this medication reduces the level of acrolein in patients. When the drug is administered to laboratory rats, it reduces chronic pain associated with paralysis. It is hoped that this medication can also reduce the pain that often accompanies spinal cord injuries. This pain can last for decades after the original injury further reducing a patient's quality of life.
If hydralazine is approved for use in treating the chronic pain suffered by those with spinal cord injuries, it could give patients some much needed relief. However, as many people in Colorado already know, new treatments can often be expensive. When a person has suffered an injury due to the negligence of another, it may be possible to receive financial restitution through a civil action. A successful lawsuit can help alleviate at least some of the financial burden that commonly accompanies such an injury. This could give patients the financial means necessary to receive the best treatment possible.
Source: medicalxpress.com, Drug may reduce chronic pain for spinal cord injuries, Emil Venere, Oct. 31, 2013